← Back to Search

Robotic Device

Robotic-Assisted Walking Rehabilitation for Spinal Cord Injury

N/A
Waitlist Available
Led By Emily J Fox, DPT, PhD
Research Sponsored by Brooks Rehabilitation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Medically stable with no acute illness, infections
Able to walk 10 feet with or without assistance, gait assistive devices and/or orthotics
Timeline
Screening 3 weeks
Treatment Varies
Follow Up daily and change in baseline to weeks 6 and 12
Awards & highlights

Study Summary

This trial will test the safety and efficacy of using a robotic device to help with locomotor training for people with spinal cord injuries, to improve walking function.

Who is the study for?
This trial is for adults aged 18-80 with chronic, incomplete spinal cord injury who can walk at least 10 feet with or without help. They must be over a year post-injury, able to consent, medically stable, and have physician approval. Excluded are those with cognitive impairments, severe joint contractures, current rehab participation, recent Botox in leg muscles affecting walking function within the last four months.Check my eligibility
What is being tested?
The study tests the Hybrid Assistive Limb (HAL), an adaptive robotic device designed to improve walking rehabilitation after spinal cord injury by matching natural human stepping patterns during locomotor training. It's being evaluated for safety and effectiveness in U.S. patients.See study design
What are the potential side effects?
While not explicitly listed in the provided information, potential side effects may include discomfort from wearing HAL equipment or fatigue due to physical exertion during rehabilitation sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently not suffering from any serious illnesses or infections.
Select...
I can walk 10 feet by myself or with help or devices.
Select...
I am between 18 and 80 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~daily and change in baseline to weeks 6 and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and daily and change in baseline to weeks 6 and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
10-Meter Walk Test (10MWT)
6-Minute Walk Test (6MWT)
Secondary outcome measures
Electromyogram (EMG) will be used to assess the neuromuscular activation of the lower extremities

Trial Design

1Treatment groups
Experimental Treatment
Group I: Locomotor training using adaptive robotExperimental Treatment1 Intervention
The intervention will consist of 60 sessions of locomotor training using the HAL adaptive robot. The training sessions will be scheduled 5 days per week for 12 weeks. A physical therapist with expertise in SCI walking rehabilitation and use of the HAL will oversee all intervention sessions. The intervention sessions will include up to a total of 40 minutes of stepping time, which may take up to 2 hours to complete due to set up time and rest breaks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hybrid Assistive Limb (HAL)
2015
N/A
~50

Find a Location

Who is running the clinical trial?

Brooks RehabilitationLead Sponsor
13 Previous Clinical Trials
1,732 Total Patients Enrolled
University of FloridaOTHER
1,340 Previous Clinical Trials
715,684 Total Patients Enrolled
Emily J Fox, DPT, PhDPrincipal InvestigatorBrooks Rehabilitation

Media Library

Hybrid Assistive Limb (HAL) (Robotic Device) Clinical Trial Eligibility Overview. Trial Name: NCT03504826 — N/A
Spinal Cord Injury Research Study Groups: Locomotor training using adaptive robot
Spinal Cord Injury Clinical Trial 2023: Hybrid Assistive Limb (HAL) Highlights & Side Effects. Trial Name: NCT03504826 — N/A
Hybrid Assistive Limb (HAL) (Robotic Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03504826 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are the elderly able to participate in this medical research endeavor?

"The eligibility criteria for this medical study specifies a minimum age of 18 and maximum age of 80."

Answered by AI

How many participants are partaking in this research endeavor?

"Correct, clinicaltrials.gov's records show that this trial is actively enrolling patients. The research was initially published on November 29th 2018 and was recently amended on December 3rd 2021. This study requires 24 participants from one medical site to take part."

Answered by AI

Who is eligible to become involved with this research project?

"This clinical trial is recruiting 24 people with spinal cord injuries aged between 18 and 80. To qualify, applicants must possess the following characteristics: Adults in age from 18 - 80 years old; diagnosed with a chronic sensory or motor incomplete spinal cord injury (ASIA Impairment Scale (AIS) B, C, D); post-injury for over one year; medically stable without acute illness/infections; obtained physician approval to join study procedures; able to walk 10 feet independently or aided by gait assistive devices and orthotics; willing to provide informed consent."

Answered by AI

Is there still room to enroll participants in this research endeavor?

"The clinical trial is currently enrolling patients, as evidenced on clinicaltrials.gov; the initial posting was November 29th 2018 and it has been updated most recently on December 3rd 2021."

Answered by AI

Who else is applying?

What site did they apply to?
Brooks Rehabilitation
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I get around with a cane and Walker.
PatientReceived 1 prior treatment
~1 spots leftby Jul 2024